Biopharmaceutical company focused on eye care.
4 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Tarsus Pharmaceuticals Inc..
The 2 sources with the most insights about Tarsus Pharmaceuticals Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
The speaker listed TARS among past altcoin positions that had lost substantial value on paper.
TARS was mentioned among the host’s weaker positions, but no individual loss figure or further analysis was provided.
Listed as one of the biotech/pharma companies the speaker holds positive views on and/or has positions in.
Held as a long position and bullish bet in the speaker's personal trading account.
The speaker listed TARS among past altcoin positions that had lost substantial value on paper.
TARS was mentioned among the host’s weaker positions, but no individual loss figure or further analysis was provided.
Listed as one of the biotech/pharma companies the speaker holds positive views on and/or has positions in.
Held as a long position and bullish bet in the speaker's personal trading account.
Other assets that creators frequently mention in the same content as Tarsus Pharmaceuticals Inc..
The most active sources covering Tarsus Pharmaceuticals Inc. (TARS) on Kazuha are @realmartinshkreli, @jakegordoncrypto. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 4 AI-extracted insights about Tarsus Pharmaceuticals Inc. (TARS) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Tarsus Pharmaceuticals Inc. (TARS) most frequently also discuss BTC, AAPL, NVDA, SUI, XRP. See the "Discussed alongside" section above for full asset pages.